Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women
Top Cited Papers
- 30 October 2000
- Vol. 27 (5) , 687-694
- https://doi.org/10.1016/s8756-3282(00)00376-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- MECHANISMS OF ACTION OF BISPHOSPHONATESAnnual Review of Pharmacology and Toxicology, 1998
- Bisphosphonates: Mechanisms of ActionEndocrine Reviews, 1998
- Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention TrialArchives of internal medicine (1960), 1997
- Prevention of Early Postmenopausal Bone Loss with Cyclical Etidronate Therapy (A Double-Blind, Placebo-Controlled Study and 1-Year Follow-Up)Journal of Clinical Endocrinology & Metabolism, 1997
- Dose-Response Relationships for Alendronate Treatment in Osteoporotic Elderly WomenJournal of Clinical Endocrinology & Metabolism, 1997
- Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective studyJournal of Bone and Mineral Research, 1996
- Effects of sodium fluoride and alendronate on the bone mineral in minipigs: A small-angle X-ray scattering and backscattered electron imaging studyJournal of Bone and Mineral Research, 1996
- The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.Journal of Clinical Investigation, 1993
- Age and disease-related changes in the mineral of boneCalcified Tissue International, 1993
- Changes in the mineral density distribution in human bone with age: Image analysis using backscattered electrons in the SEMJournal of Bone and Mineral Research, 1987